BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22214923)

  • 1. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation.
    Mul D; Wu S; de Paus RA; Oostdijk W; Lankester AC; Duyvenvoorde HA; Ruivenkamp CA; Losekoot M; Tol MJ; De Luca F; van de Vosse E; Wit JM
    Eur J Endocrinol; 2012 Apr; 166(4):743-52. PubMed ID: 22214923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical defects resulting in growth hormone insensitivity.
    Wit JM; de Luca F
    Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
    Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
    Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.
    Wu S; Walenkamp MJ; Lankester A; Bidlingmaier M; Wit JM; De Luca F
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1220-8. PubMed ID: 20080849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
    Han X; Osuntokun B; Benight N; Loesch K; Frank SJ; Denson LA
    Am J Pathol; 2006 Dec; 169(6):1999-2013. PubMed ID: 17148664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5b deficiency: lessons from STAT5b gene mutations.
    Hwa V; Nadeau K; Wit JM; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):61-75. PubMed ID: 21396575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
    Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New molecular mechanisms of growth hormone insensitivity].
    Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
    Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation.
    Bernasconi A; Marino R; Ribas A; Rossi J; Ciaccio M; Oleastro M; Ornani A; Paz R; Rivarola MA; Zelazko M; Belgorosky A
    Pediatrics; 2006 Nov; 118(5):e1584-92. PubMed ID: 17030597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene.
    Hwa V; Camacho-Hübner C; Little BM; David A; Metherell LA; El-Khatib N; Savage MO; Rosenfeld RG
    Horm Res; 2007; 68(5):218-24. PubMed ID: 17389811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity.
    Woods K
    Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.
    Edmead CE; Patel YI; Wilson A; Boulougouris G; Hall ND; Ward SG; Sansom DM
    J Immunol; 1996 Oct; 157(8):3290-7. PubMed ID: 8871623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses.
    Skånland SS; Moltu K; Berge T; Aandahl EM; Taskén K
    Biochem J; 2014 Jun; 460(3):399-410. PubMed ID: 24665965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes.
    Kim NH; Jeon S; Lee HJ; Lee AY
    J Invest Dermatol; 2007 Nov; 127(11):2612-7. PubMed ID: 17522703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of insulin-like growth factor deficiency.
    Wit JM; Oostdijk W; Losekoot M
    Endocr Dev; 2012; 23():30-41. PubMed ID: 23182818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway.
    Kim JH; Lee G; Cho YL; Kim CK; Han S; Lee H; Choi JS; Choe J; Won MH; Kwon YG; Ha KS; Kim YM
    Eur J Pharmacol; 2009 Jan; 602(2-3):422-31. PubMed ID: 19027002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.